The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
DNA hypomethylation in rheumatoid arthritis synovial fibroblasts
Open accessAbstract
Objective: Rheumatoid arthritis synovial fibroblasts (RASFs) are phenotypically activated and aggressive. We undertook this study to investigate whether the intrinsic activation of RASFs is due to global genomic hypomethylation, an epigenetic modification. Methods: Global genomic hypomethylation was assessed by immunohistochemistry, flow cytometry, and L1 promoter bisulfite sequencing. The levels of Dnmt1 were determined in synovial tissue and cultured SFs by Western blotting before and after treatment with cytokines and growth factors. Normal SFs were treated for 3 months with a nontoxic dose of the DNA hypomethylation drug 5‐azacytidine (5‐azaC), and changes in gene expression were revealed using complementary DNA arrays. The phenotypic changes were confirmed by flow cytometry. Results: In situ and in vitro, RASF DNA had fewer 5‐methylcytosine and methylated CG sites upstream of an L1 open‐reading frame than did DNA of osteoarthritis SFs, and proliferating RASFs were deficient in Dnmt1. Using 5‐azaC, we reproduced the activated phenotype of RASFs in normal SFs. One hundred eighty‐six genes were up‐regulated >2‐fold by hypomethylation, with enhanced protein expression. These included growth factors and receptors, extracellular matrix proteins, adhesion molecules, and matrix‐degrading enzymes. The hypomethylating milieu induced irreversible phenotypic changes in normal SFs, which resembled those of the activated phenotype of RASFs. Conclusion: DNA hypomethylation contributes to the chronicity of RA and could be responsible for the limitation of current therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Esteller, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072067 · Cited by 3,662
A microRNA DNA methylation signature for human cancer metastasis
Lujambio, A., Calin, G. A., Villanueva, A., Ropero, S., Sánchez-Céspedes, M., Blanco, D., Montuenga, L. M., Rossi, S., Nicoloso, M. S., Faller, W. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803055105 · Cited by 1,078
DNA hypomethylation and human diseases
Wilson, A. S., Power, B. E., & Molloy, P. L. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.007 · Cited by 804
Quantitative analysis of cytokine gene expression in rheumatoid arthritis.
Firestein, G. S., Alvaro-Gracia, J. M., & Maki, R. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.9.3347 · Cited by 598
Konttinen, Y. T., Ainola, M., Valleala, H., Ma, J., Ida, H., Mandelin, J., Kinne, R. W., Santavirta, S., Sorsa, T., López-Otín, C., et al. (1999) · Annals of the Rheumatic Diseases · doi:10.1136/ard.58.11.691 · Cited by 403
The role of mammalian DNA methyltransferases in the regulation of gene expression.
Turek-Plewa, J., & Jagodziński, P. P. (2005) · PubMed · Cited by 391
Nguyen, C. T., Weisenberger, D. J., Velicescu, M., Gonzales, F. A., Lin, J., Liang, G., & Jones, P. A. (2002) · PubMed · Cited by 383
Mechanisms of Disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis
Müller-Ladner, U., Pap, T., Gay, R. E., Neidhart, M., & Gay, S. (2005) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0047 · Cited by 334
Self-citationLafyatis, R., Remmers, E. F., Roberts, A. B., Yocum, D. E., Sporn, M. B., & Wilder, R. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114011 · Cited by 323
Wehbe, H., Henson, R., Meng, F., Mize-Berge, J., & Patel, T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2130 · Cited by 224
Methylation of Endogenous Human Retroelements in Health and Disease
Schulz, W. A., Steinhoff, C., & Florl, A. R. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-31181-5_11 · Cited by 222
Methylation-Dependent Gene Silencing Induced by Interleukin 1β via Nitric Oxide Production
Hmadcha, A., Bedoya, F. J., Sobrino, F., & Pintado, E. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1595 · Cited by 206
Liang, G., Gonzales, F. A., Jones, P. A., Orntoft, T. F., & Thykjær, T. (2002) · PubMed · Cited by 205
The Role of IL‐1 and IL‐1Ra in Joint Inflammation and Cartilage Degradation
Jacques, C., Gosset, M., Berenbaum, F., & Gabay, C. (2006) · Vitamins & Hormones · doi:10.1016/s0083-6729(06)74016-x · Cited by 196
Rheumatoid arthritis and the complement system
Okroj, M., Heinegård, D., Holmdahl, R., & Blom, A. M. (2007) · Annals of Medicine · doi:10.1080/07853890701477546 · Cited by 184
Molecular and cellular basis of rheumatoid joint destruction
Karouzakis, E., Neidhart, M., Gay, R. E., & Gay, S. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.04.011 · Cited by 167
Self-citationTakami, N., Osawa, K., Miura, Y., Komai, K., Taniguchi, M., Shiraishi, M., Sato, K., Iguchi, T., Shiozawa, K., Hashiramoto, A., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21637 · Cited by 165
Hummel, K. M., Petrow, P. K., Franz, J. K., Müller‐Ladner, U., Aicher, W. K., Gay, R. E., Brömme, D., & Gay, S. (1998) · PubMed · Cited by 148
Self-citationReview: Immune cells and mediators of inflammatory arthritis
Schett, G. A. (2008) · Autoimmunity · doi:10.1080/08916930701694717 · Cited by 120
Central Role of Thrombospondin-1 in the Activation and Clonal Expansion of Inflammatory T Cells
Vallejo, A. N., Muegge, L. O., Klimiuk, P. A., Weyand, C. M., & Goronzy, J. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.2947 · Cited by 119
Sato, N., Maehara, N., Su, G. H., & Goggins, M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.4.327 · Cited by 118
ONCOGENES IN RHEUMATOID ARTHRITIS
Müller‐Ladner, U., Kriegsmann, J., Gay, R. E., & Gay, S. (1995) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00462-2 · Cited by 105
Self-citationRinaldi, N., Schwarz-Eywill, M., Weis, D., Leppelmann-Jansen, P., Lukoschek, M., Keilholz, U., & Barth, T. F. E. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.1.45 · Cited by 98
Neidhart, M., Zaucke, F., von Knoch, R., Jüngel, A., Michel, B. A., Gay, R. E., & Gay, S. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.023135 · Cited by 86
Self-citationvan Bilsen, J. H. M., van Dongen, H., Lard, L. R., van der Voort, E. I. H., Elferink, D. G., Bakker, A. M., Miltenburg, A. M. M., Huizinga, T. W. J., de Vries, R. R. P., & Toes, R. E. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407704101 · Cited by 80
Oncostatin M in the anti-inflammatory response
Wahl, A. F., & Wallace, P. M. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.90003.iii75 · Cited by 71
Rutkauskaite, E., Volkmer, D., Shigeyama, Y., Schedel, J., Pap, G., Müller‐Ladner, U., Meinecke, I., Alexander, D., Gay, R. E., Drynda, S., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21156 · Cited by 58
Self-citationThe role of DNA methyltransferase 1 in growth control
Szyf, M. (2001) · Frontiers in bioscience · doi:10.2741/szyf · Cited by 55
Masuda, K., Masuda, R., Neidhart, M., Simmen, B. R., Michel, B. A., Müller‐Ladner, U., Gay, R. E., & Gay, S. (2002) · Arthritis Research & Therapy · doi:10.1186/ar427 · Cited by 51
Self-citationAnti-TNF Antibodies: Lessons from the Past, Roadmap for the Future
Shealy, D. J., & Visvanathan, S. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-73259-4_5 · Cited by 50
Khan, M., Pelengaris, S., Cooper, M. B., Smith, C. C. T., Evan, G. I., & Betteridge, J. D. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.07.001 · Cited by 45
Cysteine and serine proteases of synovial tissue in rheumatoid arthritis and osteoarthritis
Solau‐Gervais, E., Zerimech, F., Lemaire, R., Fontaine, C., Huet, G., & Flipo, R. (2007) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740701340172 · Cited by 36
Transforming growth factor β stimulates rheumatoid synovial fibroblasts via the type II receptor
Bira, Y., Tani, K., Nishioka, Y., Miyata, J., Sato, K., Hayashi, A., Nakaya, Y., & Sone, S. (2005) · Modern Rheumatology · doi:10.1007/s10165-004-0378-2 · Cited by 34
Neidhart (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200012)43:12 · Cited by 1
Cited by
Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes
Nygaard, G., & Firestein, G. S. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0413-5 · Cited by 928
The pathogenesis of rheumatoid arthritis
Alivernini, S., Firestein, G. S., & McInnes, I. B. (2022) · Immunity · doi:10.1016/j.immuni.2022.11.009 · Cited by 702
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
Ding, Q., Hu, W., Wang, R., Yang, Q., Zhu, M., Li, M., Cai, J., Rose, P., Mao, J., & Zhu, Y. Z. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01331-9 · Cited by 478
Strategies toward rheumatoid arthritis therapy; the old and the new
Abbasi, M., Mousavi, M. J., Jamalzehi, S., Alimohammadi, R., Bezvan, M. H., Mohammadi, H., & Aslani, S. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27860 · Cited by 443
Stanczyk, J., Ospelt, C., Karouzakis, E., Filer, A., Raza, K., Kolling, C., Gay, R., Buckley, C. D., Tak, P. P., Gay, S., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30115 · Cited by 407
Self-citation
Metadata
- Authors
- Karouzakis, E., Gay, R. E., Michel, B. A., Gay, S., & Neidhart, M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2009-11-30
- Volume
- 60
- Issue
- 12
- Pages
- 3613-3622
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1988094624
- Cited by
- 308
- References
- 34
- FWCI
- 12.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.